MAPT and Cognitive impairment: For instance, in a mouse model of AD, genetic ablation of HDAC6 alleviated cognitive impairment without impacting plaque burden, which may suggest that beneficial consequences of loss of HDAC6 expression are due to effects on endogenous tau, though this has not yet been assessed in this model [47].